{
  "company_number": "SC520998",
  "name": "Antibody Analytics Limited",
  "url": "/company/SC520998",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2015-11-24",
  "dissolved_on": null,
  "sic_codes": [
    {
      "code": "74909",
      "description": "Other professional, scientific and technical activities n.e.c.",
      "section": "M",
      "section_name": "Professional, scientific and technical activities",
      "url": "/sic/74909"
    }
  ],
  "registered_address": {
    "id": 774393,
    "url": "/address/774393",
    "line1": "ROUKEN DISCOVERY CENTRE",
    "line2": "BRAIDHURST INDUSTRIAL ESTATE",
    "post_town": "MOTHERWELL",
    "county": "NORTH LANARKSHIRE",
    "country": "SCOTLAND",
    "postcode": "ML1 3ST"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/SC520998",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2027-09-30",
    "last_made_up": "2025-12-31",
    "category": "FULL",
    "filings": [
      {
        "url": "/company/SC520998/accounts/2025-12-31",
        "made_up_date": "2025-12-31",
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "entity_name": "Antibody Analytics Limited T/a Roukenbio",
        "dormant": false,
        "average_employees": "1.01",
        "tangible_fixed_assets": "7153131.00",
        "debtors": "2439939.00",
        "cash_bank_in_hand": "2503374.00",
        "current_assets": "5768263.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "3160648.00",
        "total_assets_less_current_liabilities": "10313779.00",
        "net_assets_liabilities": "3930254.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "111.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": "5389142.00",
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": "577371.00",
        "tax_on_profit": "-919693.00",
        "profit_loss_for_period": "1497064.00",
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2026.zip"
      },
      {
        "url": "/company/SC520998/accounts/2024-12-31",
        "made_up_date": "2024-12-31",
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "entity_name": "Antibody Analytics Limited T/a Roukenbio",
        "dormant": false,
        "average_employees": "84.00",
        "tangible_fixed_assets": "6362921.00",
        "debtors": "1577287.00",
        "cash_bank_in_hand": "3005637.00",
        "current_assets": "5412074.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-3631795.00",
        "total_assets_less_current_liabilities": "2731126.00",
        "net_assets_liabilities": "2433190.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "111.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": "4449746.00",
        "gross_profit_loss": null,
        "administrative_expenses": "3459651.00",
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": "-696540.00",
        "tax_on_profit": "-22619.00",
        "profit_loss_for_period": "-673921.00",
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2025.zip"
      },
      {
        "url": "/company/SC520998/accounts/2023-12-31",
        "made_up_date": "2023-12-31",
        "period_start": "2023-12-31",
        "period_end": "2023-12-31",
        "entity_name": "Antibody Analytics Limited",
        "dormant": false,
        "average_employees": "64.00",
        "tangible_fixed_assets": "2197903.00",
        "debtors": "846466.00",
        "cash_bank_in_hand": "6272425.00",
        "current_assets": "7240363.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "6413412.00",
        "total_assets_less_current_liabilities": "8611315.00",
        "net_assets_liabilities": "1194646.00",
        "called_up_share_capital": "111.00",
        "profit_loss_account_reserve": "1376203.00",
        "shareholder_funds": "111.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2024.zip"
      },
      {
        "url": "/company/SC520998/accounts/2022-12-31",
        "made_up_date": "2022-12-31",
        "period_start": "2022-12-31",
        "period_end": "2022-12-31",
        "entity_name": "Antibody Analytics Limited",
        "dormant": false,
        "average_employees": "60.00",
        "tangible_fixed_assets": "1889999.00",
        "debtors": "585904.00",
        "cash_bank_in_hand": "913276.00",
        "current_assets": "1595090.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "586703.00",
        "total_assets_less_current_liabilities": "2476702.00",
        "net_assets_liabilities": "767505.00",
        "called_up_share_capital": "110.00",
        "profit_loss_account_reserve": "662405.00",
        "shareholder_funds": "110.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-August2023.zip"
      },
      {
        "url": "/company/SC520998/accounts/2021-12-31",
        "made_up_date": "2021-12-31",
        "period_start": "2021-12-31",
        "period_end": "2021-12-31",
        "entity_name": "Antibody Analytics Limited",
        "dormant": false,
        "average_employees": "44.00",
        "tangible_fixed_assets": "1408182.00",
        "debtors": "576919.00",
        "cash_bank_in_hand": "842559.00",
        "current_assets": "1520643.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "562424.00",
        "total_assets_less_current_liabilities": "1970606.00",
        "net_assets_liabilities": "846155.00",
        "called_up_share_capital": "110.00",
        "profit_loss_account_reserve": "741055.00",
        "shareholder_funds": "110.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-August2022.zip"
      },
      {
        "url": "/company/SC520998/accounts/2020-12-31",
        "made_up_date": "2020-12-31",
        "period_start": "2020-12-31",
        "period_end": "2020-12-31",
        "entity_name": "Antibody Analytics Limited",
        "dormant": false,
        "average_employees": "38.00",
        "tangible_fixed_assets": "807895.00",
        "debtors": "437025.00",
        "cash_bank_in_hand": "964183.00",
        "current_assets": "1401208.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "556862.00",
        "total_assets_less_current_liabilities": "1364757.00",
        "net_assets_liabilities": "298893.00",
        "called_up_share_capital": "110.00",
        "profit_loss_account_reserve": "193793.00",
        "shareholder_funds": "110.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2021.zip"
      },
      {
        "url": "/company/SC520998/accounts/2019-12-31",
        "made_up_date": "2019-12-31",
        "period_start": "2019-12-31",
        "period_end": "2019-12-31",
        "entity_name": "Antibody Analytics Limited",
        "dormant": false,
        "average_employees": "26.00",
        "tangible_fixed_assets": "695067.00",
        "debtors": "557871.00",
        "cash_bank_in_hand": "955335.00",
        "current_assets": "1513206.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "542224.00",
        "total_assets_less_current_liabilities": "1237291.00",
        "net_assets_liabilities": "609638.00",
        "called_up_share_capital": "110.00",
        "profit_loss_account_reserve": "504538.00",
        "shareholder_funds": "110.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2020.zip"
      },
      {
        "url": "/company/SC520998/accounts/2018-12-31",
        "made_up_date": "2018-12-31",
        "period_start": "2018-12-31",
        "period_end": "2018-12-31",
        "entity_name": "Antibody Analytics Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "556917.00",
        "debtors": "603805.00",
        "cash_bank_in_hand": "325406.00",
        "current_assets": "929211.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "126096.00",
        "total_assets_less_current_liabilities": "683013.00",
        "net_assets_liabilities": "616434.00",
        "called_up_share_capital": "100.00",
        "profit_loss_account_reserve": "616334.00",
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2019.zip"
      },
      {
        "url": "/company/SC520998/accounts/2017-12-31",
        "made_up_date": "2017-12-31",
        "period_start": "2017-12-31",
        "period_end": "2017-12-31",
        "entity_name": "Antibody Analytics Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "290735.00",
        "debtors": "402274.00",
        "cash_bank_in_hand": "142733.00",
        "current_assets": "545007.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-54277.00",
        "total_assets_less_current_liabilities": "236458.00",
        "net_assets_liabilities": "236458.00",
        "called_up_share_capital": "100.00",
        "profit_loss_account_reserve": "236358.00",
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2018.zip"
      },
      {
        "url": "/company/SC520998/accounts/2016-12-31",
        "made_up_date": "2016-12-31",
        "period_start": "2016-12-31",
        "period_end": "2016-12-31",
        "entity_name": "Antibody Analytics Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "72449.00",
        "debtors": "48248.00",
        "cash_bank_in_hand": "115089.00",
        "current_assets": "163337.00",
        "creditors_due_within_one_year": "412117.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-248780.00",
        "total_assets_less_current_liabilities": "-108264.00",
        "net_assets_liabilities": "-108264.00",
        "called_up_share_capital": "100.00",
        "profit_loss_account_reserve": "-108364.00",
        "shareholder_funds": "-108264.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-August2017.zip"
      }
    ],
    "pdf_only_filings": [],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/SC520998/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2026-12-10",
    "last_made_up": "2025-11-26"
  },
  "officers": [],
  "psc": [
    {
      "name": "Miss Michahaila Julia Downie",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/3378911",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent",
        "voting-rights-25-to-50-percent"
      ],
      "notified_on": "2016-04-06",
      "ceased_on": "2023-10-12",
      "nationality": "British",
      "country_of_residence": "Scotland",
      "source": "snapshot"
    },
    {
      "name": "Mr Andrew Richard Upsall",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/384711",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent",
        "voting-rights-25-to-50-percent"
      ],
      "notified_on": "2016-04-06",
      "ceased_on": "2023-10-12",
      "nationality": "British",
      "country_of_residence": "Scotland",
      "source": "snapshot"
    },
    {
      "name": "Project Steel Acquireco Limited",
      "kind": "corporate-entity-person-with-significant-control",
      "person_url": null,
      "controlling_company_url": "/company/SC780681",
      "natures_of_control": [
        "ownership-of-shares-75-to-100-percent",
        "voting-rights-75-to-100-percent",
        "right-to-appoint-and-remove-directors"
      ],
      "notified_on": "2023-10-12",
      "ceased_on": null,
      "nationality": "",
      "country_of_residence": "",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-08-01",
    "retrieved_at": "2026-08-02T07:01:15.144032+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}